Golidocitinib in Combination With Sintilimab for PD-L1 Selected Treatment Locally Advanced or Metastatic Non-Small Cell Lung Cancer(NSCLC)
Clinical trial NCT06198907 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06198907
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-01
- Primary completion
- 2026-12-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.